{
    "organizations": [],
    "uuid": "ad0aedf2007f84ad23e1f4e289dd59265a740dd8",
    "author": "",
    "url": "https://www.reuters.com/article/brief-paratek-completes-submission-of-ne/brief-paratek-completes-submission-of-new-drug-applications-to-u-s-fda-idUSASB0C3WL",
    "ord_in_thread": 0,
    "title": "BRIEF-Paratek Completes Submission Of New Drug Applications To U.S.FDA",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 39 PM / Updated 11 minutes ago BRIEF-Paratek Completes Submission Of New Drug Applications To U.S.FDA Reuters Staff 1 Min Read \nFeb 5 (Reuters) - Paratek Pharmaceuticals Inc: \n* PARATEK COMPLETES SUBMISSION OF NEW DRUG APPLICATIONS TO U.S. FOOD AND DRUG ADMINISTRATION FOR ORAL AND INTRAVENOUS OMADACYCLINE FOR PNEUMONIA AND SKIN INFECTIONS Source text for Eikon: Further company coverage:",
    "published": "2018-02-05T14:39:00.000+02:00",
    "crawled": "2018-02-05T14:57:57.003+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "updated",
        "minute",
        "ago",
        "completes",
        "submission",
        "new",
        "drug",
        "application",
        "reuters",
        "staff",
        "min",
        "read",
        "feb",
        "reuters",
        "paratek",
        "pharmaceutical",
        "inc",
        "paratek",
        "completes",
        "submission",
        "new",
        "drug",
        "application",
        "food",
        "drug",
        "administration",
        "oral",
        "intravenous",
        "omadacycline",
        "pneumonia",
        "skin",
        "infection",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}